https://www.clinicalister.com/reports A free weekly report on the global clinical-trial landscape: new trials, FDA/EMA approvals, drug shortages, terminations and top movers. Source-traceable. en Mon, 05 Oct 2026 00:00:00 GMT https://www.clinicalister.com/reports/2026-10-04/ https://www.clinicalister.com/reports/2026-10-04/ Sun, 04 Oct 2026 00:00:00 GMT Clinical Trials Pulse, week ending Oct 4, 2026: FDA approved Unknown, MUPIROCIN CALCIUM, PREDNISOLONE ACETATE and 2 more; new shortages: Ivermectin Tablet. https://www.clinicalister.com/reports/2026-09-27/ https://www.clinicalister.com/reports/2026-09-27/ Sun, 27 Sep 2026 00:00:00 GMT Clinical Trials Pulse, week ending Sep 27, 2026: new shortages: Arsenic Trioxide Injection. https://www.clinicalister.com/reports/2026-09-20/ https://www.clinicalister.com/reports/2026-09-20/ Sun, 20 Sep 2026 00:00:00 GMT Clinical Trials Pulse, week ending Sep 20, 2026: FDA approved EPINEPHRINE; new shortages: Rivastigmine Film, Extended Release, Melphalan Hydrochloride Injection and 1 more. https://www.clinicalister.com/reports/2026-09-13/ https://www.clinicalister.com/reports/2026-09-13/ Sun, 13 Sep 2026 00:00:00 GMT Clinical Trials Pulse, week ending Sep 13, 2026: FDA approved BRIVARACETAM and IBRUTINIB; new shortages: Dextrose Monohydrate, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride Solution and Imipenem Anhydrous, Cilastatin, and Relebactam Anhydrous Injection. https://www.clinicalister.com/reports/2026-09-06/ https://www.clinicalister.com/reports/2026-09-06/ Sun, 06 Sep 2026 00:00:00 GMT Clinical Trials Pulse, week ending Sep 6, 2026: FDA approved ELAGOLIX, ESTRADIOL AND NORETHINDRONE ACETATE AND ELAGOLIX, POMALIDOMIDE, POMALIDOMIDE and 4 more; new shortages: Glycerol Phenylbutyrate Oral Liquid, Insulin Glargine-aglr Injection and 6 more. https://www.clinicalister.com/reports/2026-08-30/ https://www.clinicalister.com/reports/2026-08-30/ Sun, 30 Aug 2026 00:00:00 GMT Clinical Trials Pulse, week ending Aug 30, 2026: new shortages: Pentostatin Injection, Liraglutide Injection and 2 more. https://www.clinicalister.com/reports/2026-08-23/ https://www.clinicalister.com/reports/2026-08-23/ Sun, 23 Aug 2026 00:00:00 GMT Clinical Trials Pulse, week ending Aug 23, 2026: FDA approved Unknown, CARBIDOPA, LEVODOPA, NALOXONE HYDROCHLORIDE and 4 more. https://www.clinicalister.com/reports/2026-08-16/ https://www.clinicalister.com/reports/2026-08-16/ Sun, 16 Aug 2026 00:00:00 GMT Clinical Trials Pulse, week ending Aug 16, 2026: FDA approved FOSFOMYCIN TROMETHAMINE, TRIAMCINOLONE ACETONIDE, VALSARTAN and 2 more; new shortages: Fulvestrant Injection, Diclofenac Sodium Tablet, Delayed Release and 2 more. https://www.clinicalister.com/reports/2026-08-09/ https://www.clinicalister.com/reports/2026-08-09/ Sun, 09 Aug 2026 00:00:00 GMT Clinical Trials Pulse, week ending Aug 9, 2026: FDA approved OVEPOREXTON, SACUBITRIL; VALSARTAN, ORFORGLIPRON and 3 more; new shortages: Calcium Chloride; Dextrose; Magnesium Chloride; Sodium Chloride; Sodium Lactate Intraperitoneal Injection, Solution. https://www.clinicalister.com/reports/2026-08-02/ https://www.clinicalister.com/reports/2026-08-02/ Sun, 02 Aug 2026 00:00:00 GMT Clinical Trials Pulse, week ending Aug 2, 2026: FDA approved CLONIDINE HYDROCHLORIDE, Unknown, Ruxolitinib and 23 more; new shortages: Doxycycline Hyclate Tablet, Delayed Release, Glycopyrrolate Injection and 1 more. https://www.clinicalister.com/reports/2026-07-26/ https://www.clinicalister.com/reports/2026-07-26/ Sun, 26 Jul 2026 00:00:00 GMT Clinical Trials Pulse, week ending Jul 26, 2026: FDA approved ADAPALENE; BENZOYL PEROXIDE, CANAGLIFLOZIN, BUPROPION HYDROCHLORIDE and 5 more; new shortages: Lopinavir and Ritonavir Oral Solution, Lopinavir and Ritonavir Tablet and 11 more. https://www.clinicalister.com/reports/2026-07-19/ https://www.clinicalister.com/reports/2026-07-19/ Sun, 19 Jul 2026 00:00:00 GMT Clinical Trials Pulse, week ending Jul 19, 2026: FDA approved ENLICITIDE CHLORIDE, ENLICITIDE, AFATINIB DIMALEATE and 6 more; new shortages: Tobramycin Sulfate Injection. https://www.clinicalister.com/reports/2026-07-12/ https://www.clinicalister.com/reports/2026-07-12/ Sun, 12 Jul 2026 00:00:00 GMT Clinical Trials Pulse, week ending Jul 12, 2026: FDA approved Unknown, ILOPROST, RILPIVIRINE HYDROCHLORIDE and 18 more; new shortages: Travoprost Ophthalmic Solution.